01.09.2001 | Original Article
ALVAC-mediated gene transfer is efficient in lymphoid malignancies of T-and early B-cell origin, but not in tumors arising from mature B-cells
Erschienen in: Cancer Immunology, Immunotherapy | Ausgabe 7/2001
Einloggen, um Zugang zu erhalten